Presentation Information
[28-28-pm05S]Development of novel covalent drugs utilizing the warhead reactivity control by cancer specific enzymes
○Tadashi Imoto1, Kyohhei Fujita2, Takuya Hashimoto3, Yasuteru Urano1,2 (1. Grad. Sch. Pharm. Sci., The University of Tokyo, 2. Grad. Sch. Med. Sci., The University of Tokyo, 3. Pioneering Research Institute, RIKEN)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
